The changes in Adora1, Slc6a15, and Comt expression may result in changes in the function of encoded proteins and subsequent alterations within adenosine, glutamatergic, and monoaminergic systems, all of which are critically involved in depression pathophysiology and treatment. Here, ADORA1 is linked to depressive symptom measurement.